Important milestone for cancer patients in Norway:
Åslaug Helland, oncologist and group leader in the department will lead a new center for clinical treatment research that receives major funding from The Research Council of Norway and the Norwegian Cancer Society:
The Research Council of Norway and the Norwegian Cancer Society have allocated 128 mill. NOK for a Centre for Clincial Treatment Research for treatment of cancer.
"This funding is an important contribution to Norwegian cancer research and will ensure that more patients will be included into clinical trials. The aim is new and better treatment alternatives for hard-to-treat cancers. We will develop next generation diagnostics and treatment for increased overall survival and quality of life for cancer patients all over Norway" says Åslaug Helland, leader of the centre.
Conferral ceremony 30. September 2021
Tine Alver and Zhi Zhao receiving their PhD ceremonial diplomas
Tine Alver and Zhi Zhao from our department, received their PhD ceremonial diplomas in the University's ceremonial hall, the Aula, on 30. September 2021.
Hermansen JU, Athanasiadis P, Yin Y, Rise AF, Arribas AJ, Cascione L, Russnes HG, Helland Å, Mato AR, Bertoni F, Tjønnfjord GE, Aittokallio T, Skånland SS(2025) Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient Cell Death Dis, 16(1), 555 DOI 10.1038/s41419-025-07884-7, PubMed 40701968
Pedersen CA, Fleischer T, Wess M, Midtbust E, Andersen MK, Viset T, Størkersen Ø, Rye MB, Tessem MB(2025) DNA methylation in normal-appearing tissue associated with prostate cancer recurrence and metastasis Clin Epigenetics, 17(1), 127 DOI 10.1186/s13148-025-01932-x, PubMed 40691608
Stålberg SM, Silwal-Pandit L, Hamfjord J, Nebdal DJH, Lehtiö J, Lingjærde OC, Skålhegg BS, Kure EH(2025) Elevated KRAS protein level is associated with better survival in pancreatic cancer BMC Cancer, 25(1), 1080 DOI 10.1186/s12885-025-14461-w, PubMed 40596921